MNPR smart money

Monopar Therapeutics (MNPR): 1 insider buy, 4 top funds holding it in the public filings.

Insider buys, 12 months$105k

Insider buys

FiledWhoRoleAmountPrice
2025-12-29Vu Quan AnhChief Financial Officer$105k$69.95

Top 100 funds holding it

#FundChangeWeightValue
19Tcg Crossover Management, LLC0.46%$16M
50Siren, L.L.C.0.51%$22M
76Polar Capital Holdings PLC0.05%$17M
86Adar1 Capital Management, LLCTRIM -18%0.66%$14M
Open the live smart money map